These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11457558

  • 1. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG, Hannant D, Cullinane AA, Prendergast MJ, Mumford JA, Nelly M, Kydd JH, Weststrate MW, van den Hoven R.
    Vaccine; 2001 Jul 20; 19(30):4307-17. PubMed ID: 11457558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH, Wattrang E, Hannant D.
    Vet Immunol Immunopathol; 2003 Dec 15; 96(3-4):207-17. PubMed ID: 14592733
    [Abstract] [Full Text] [Related]

  • 6. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine.
    Foote CE, Love DN, Gilkerson JR, Whalley JM.
    Vet Microbiol; 2002 Aug 02; 88(1):13-25. PubMed ID: 12119135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection.
    Kydd JH, Hannant D, Robinson RS, Bryant N, Osterrieder N.
    Vaccine; 2020 Jan 10; 38(2):388-398. PubMed ID: 31629571
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of EHV-1 and EHV-4 DNA in unweaned Thoroughbred foals from vaccinated mares on a large stud farm.
    Foote CE, Love DN, Gilkerson JR, Whalley JM.
    Equine Vet J; 2004 May 10; 36(4):341-5. PubMed ID: 15163042
    [Abstract] [Full Text] [Related]

  • 12. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR, Bateman H, Williams J, Didlick S.
    Vet Microbiol; 2003 Jan 02; 91(1):23-39. PubMed ID: 12441229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 15. EHV-1 and EHV-4 infection in vaccinated mares and their foals.
    Foote CE, Love DN, Gilkerson JR, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):41-6. PubMed ID: 16513181
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2005 May 01; 105(1-2):47-57. PubMed ID: 15797474
    [Abstract] [Full Text] [Related]

  • 18. Concurrent vaccination against equine influenza and equine herpesvirus - a practical approach.
    Gildea S, Sanchez Higgins MJ, Johnson G, Walsh C, Cullinane A.
    Influenza Other Respir Viruses; 2016 Sep 01; 10(5):433-7. PubMed ID: 27169603
    [Abstract] [Full Text] [Related]

  • 19. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE, Raidal SL, Pecenpetelovska G, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):97-108. PubMed ID: 16504306
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.